- Home
- PLUT vs TELA Comparison
PLUT vs TELA Comparison
Compare PLUT & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUT
- TELA
- Stock Information
- Founded
- PLUT 2018
- TELA 2012
- Country
- PLUT Hong Kong
- TELA United States
- Employees
- PLUT N/A
- TELA N/A
- Industry
- PLUT
- TELA Medical/Dental Instruments
- Sector
- PLUT
- TELA Health Care
- Exchange
- PLUT NYSE
- TELA Nasdaq
- Market Cap
- PLUT 35.6M
- TELA 36.4M
- IPO Year
- PLUT 2025
- TELA 2019
- Fundamental
- Price
- PLUT $2.30
- TELA $2.04
- Analyst Decision
- PLUT
- TELA Strong Buy
- Analyst Count
- PLUT 0
- TELA 4
- Target Price
- PLUT N/A
- TELA $6.00
- AVG Volume (30 Days)
- PLUT 36.2K
- TELA 125.8K
- Earning Date
- PLUT 01-01-0001
- TELA 08-11-2025
- Dividend Yield
- PLUT N/A
- TELA N/A
- EPS Growth
- PLUT N/A
- TELA N/A
- EPS
- PLUT N/A
- TELA N/A
- Revenue
- PLUT $1,435,597.00
- TELA $71,217,000.00
- Revenue This Year
- PLUT N/A
- TELA $26.67
- Revenue Next Year
- PLUT N/A
- TELA $22.63
- P/E Ratio
- PLUT N/A
- TELA N/A
- Revenue Growth
- PLUT 1.42
- TELA 12.78
- 52 Week Low
- PLUT $2.04
- TELA $0.86
- 52 Week High
- PLUT $4.22
- TELA $5.18
- Technical
- Relative Strength Index (RSI)
- PLUT N/A
- TELA 65.71
- Support Level
- PLUT N/A
- TELA $1.85
- Resistance Level
- PLUT N/A
- TELA $1.94
- Average True Range (ATR)
- PLUT 0.00
- TELA 0.19
- MACD
- PLUT 0.00
- TELA 0.00
- Stochastic Oscillator
- PLUT 0.00
- TELA 91.80
About PLUT PLUTUS FINANCIAL GROUP LIMITED
Plutus Financial Group Ltd provides financial services. It mainly offers (i) securities dealings and brokerage services (ii) margin financing services and (iii) underwriting and placing services.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.